Active SanctioncompanyID: us-uflpa-078c88b2493b38c5192ae2636c25b6778980e04b

Sichuan Yuan’an Pharmaceutical Co., Ltd.

Primary Source
US DHS UFLPA
Coverage
cn
Risk Tier
Critical
Last Updated
2026-07-26

Compliance Profile

"Risk Warning: Confirming the inclusion of Sichuan Yuan’an Pharmaceutical Co., Ltd. (Entity) in global watchlists, including US DHS UFLPA. Transactions or engagement may require review."

Banking Impact

Due to designation on US DHS UFLPA, processing any financial operations for this counterparty poses severe compliance risks, including secondary sanctions and asset forfeiture.

Legal Status

Strict embargo applies to commercial engagement. Any attempted contracts or supply chain interactions must be scrutinized against statutory prohibitions.

Official Source Metadata

Source: Global Sanctions
Full Legal NameSichuan Yuan’an Pharmaceutical Co., Ltd.
Source Records
US DHS UFLPA
Enforcement TypeGlobal Sanctions
Risk Topicssanction

Associated Subject Network

"Hassan Al-nabi
IL MOD CRYPTO
"Zayn Al-ustad
IL MOD CRYPTO
"Ківі Банк" (Акціонерне Товариство)
Акционерное общество "КИВИ"
UA NSDC SANCTIONS
'Abbas Katerji
US OFAC SDN

Compliance Context Review

Independent Risk Assessment

SIC Group prepares source-backed risk context, exposure memos, and remediation pathways for entities seeking to clarify a public record or counterparty signal.

Source-list verification
Banking and counterparty exposure memo
Regulatory status and remediation triage
Request Risk Assessment
Confidential Review
Export PDFSubscriber Only